She has extensive clinical and research experience in both areas and also holds an academic appointment in the Viral Hepatitis program at Kirby Institute. She has had involvement in many prior ASHM led initiatives and teaching programs including HCV S100 programs, B positive and ASHM conferences. She has an ideal background to contribute to the Board particularly as ASHM continues to expand into viral hepatitis in addition to HIV.